Role of Indocyanine Green in Predicting Post-Transarterial Chemoembolization Liver Failure in Hepatocellular Carcinoma

Yang, 2010, Hepatocellular carcinoma: a global view, Nat Rev Gastroenterol Hepatol, 7, 448, 10.1038/nrgastro.2010.100 Dikshit, 2012, Cancer mortality in India: a nationally representative survey, Lancet, 379, 1807, 10.1016/S0140-6736(12)60358-4 Paul, 2009, Clinical profile, etiology and therapeutic outcome in 324 hepatocellular carcinoma patients at a tertiary care center in India, Oncology, 77, 162, 10.1159/000231886 Groupe d’Etude et de Traitement du Carcinome Hépatocellulaire, 1995, A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma, N Engl J Med, 332, 1256 Bruix, 2011, Management of hepatocellular carcinoma: an update, Hepatol Baltim Md, 53, 1020, 10.1002/hep.24199 Takayasu, 2006, Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients, Gastroenterology, 131, 461, 10.1053/j.gastro.2006.05.021 Hsin, 2011, Liver failure after transarterial chemoembolization for patients with hepatocellular carcinoma and ascites: incidence, risk factors, and prognostic prediction, J Clin Gastroenterol, 45, 556, 10.1097/MCG.0b013e318210ff17 Jeon, 2007, Incidence and risk factors of acute hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma, Korean J Gastroenterol, 50, 176 Okochi, 2002, ICG pulse spectrophotometry for perioperative liver function in hepatectomy, J Surg Res, 103, 109, 10.1006/jsre.2001.6328 Mandell, 2002, Elimination of indocyanine green in the perioperative evaluation of donor liver function, Anesth Analg, 95, 1182, 10.1097/00000539-200211000-00010 Levesque, 2009, Plasma disappearance rate of indocyanine green: a tool to evaluate early graft outcome after liver transplantation, Liver Transpl, 15, 1358, 10.1002/lt.21805 Hsieh, 2004, Accuracy of indocyanine green pulse spectrophotometry clearance test for liver function prediction in transplanted patients, World J Gastroenterol, 10, 2394, 10.3748/wjg.v10.i16.2394 Merle, 2009, Sensitivity and specificity of plasma disappearance rate of indocyanine green as a prognostic indicator in acute liver failure, BMC Gastroenterol, 9, 91, 10.1186/1471-230X-9-91 Cheng, 2016, Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis, Eur J Gastroenterol Hepatol, 28, 444, 10.1097/MEG.0000000000000538 Sakka, 2006, Relation between indocyanine green (ICG) plasma disappearance rate and ICG blood clearance in critically ill patients, Intensive Care Med, 32, 766, 10.1007/s00134-006-0109-6 Pugh, 1973, Transection of the oesophagus for bleeding oesophageal varices, Br J Surg, 60, 646, 10.1002/bjs.1800600817 Malinchoc, 2000, A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts, Hepatol Baltim Md, 31, 864, 10.1053/he.2000.5852 Biggins, 2006, Evidence-based incorporation of serum sodium concentration into MELD, Gastroenterology, 130, 1652, 10.1053/j.gastro.2006.02.010 Brown, 1997, Imaging of hepatic cirrhosis, Radiology, 202, 1, 10.1148/radiology.202.1.8988182 Llovet, 2004, The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma, Liver Transpl, 10, S115, 10.1002/lt.20034 Oken, 1982, Toxicity and response criteria of the Eastern Cooperative Oncology Group, Am J Clin Oncol, 5, 649, 10.1097/00000421-198212000-00014 Paul, 2011, Trans-arterial chemoembolization (TACE) in patients with unresectable hepatocellular carcinoma: experience from a tertiary care centre in India, Indian J Radiol Imaging, 21, 113 Purcell, 2006, Indocyanine green elimination: a comparison of the LiMON and serial blood sampling methods, ANZ J Surg, 76, 75, 10.1111/j.1445-2197.2006.03643.x Mizuguchi, 2014, Preoperative liver function assessments to estimate the prognosis and safety of liver resections, Surg Today, 44, 1, 10.1007/s00595-013-0534-4 Min, 2013, Risk factors and a predictive model for acute hepatic failure after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma, Liver Int, 33, 197, 10.1111/liv.12023 Chan, 2002, A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma, Cancer, 94, 1747, 10.1002/cncr.10407